Colin Reisner

Colin Reisner

Vorstandsvorsitzender bei
Pearl Therapeutics, Inc.
Health Technology
Consumer Services
Commercial Services

Profil

Colin Reisner is currently Chief Executive Officer at Pearl Therapeutics, Inc. since 2007 and a Member of the American Thoracic Society, Inc. Former positions include Executive Director-Global Respiratory Development at Novartis Corp., Senior Director-Respiratory Division at GlaxoSmithKline, Inc., Head-Clinical Respiratory at AstraZeneca PLC, Assistant Consulting Professor at Duke University, Assistant Consulting Professor at Yale University, and Principal at Boehringer Ingelheim Corp.
Education includes undergraduate studies at the University of the Witwatersrand.

Aktive Positionen von Colin Reisner

UnternehmenPositionBeginn
Vorstandsvorsitzender 01.10.2007
Corporate Officer/Principal -

Ehemalige bekannte Positionen von Colin Reisner

UnternehmenPositionEnde
ASTRAZENECA PLC Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Colin Reisner im Detail an

Ausbildung von Colin Reisner

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

30

Beziehungen ersten Grades

9

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen9

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

  1. Börse
  2. Insiders
  3. Colin Reisner